RESUMEN
In raising murine hybridoma antibodies against Epstein-Barr virus (EBV)-induced membrane antigens (MA), we found one antibody that blocked the release of infectious EBV from cultured P3HR-1 cells. This monoclonal antibody (mAb) recognized a 200 kD, phosphonoacetic acid-sensitive (late) MA, and did not directly neutralize virus without complement. When this mAb was added to 33 degrees C-cultured, spontaneously EBV-producing P3HR-1 cells, the intracellular expression of viral capsid antigen and infectious virus was not inhibited, but the appearance of infectious virus in the culture medium was significantly reduced. The duration of this suppression was dependent upon the concentration of the mAb, an effect being observed to a 1:4 X 10(5) titer of the ascites mAb preparation. A more acute effect of suppression of EBV release was observed in a second model of 12-o-tetradecanoyl phorbol-13-acetate and n-butyrate induction of EBV in 37 degrees C-cultured P3HR-1 cells. Again, intracellular infectious virus production was not inhibited, but the level of infectious virus in the culture medium was significantly reduced as early as 1 and 2 d of culture with antibody. This effect was reversed within 31 h after replacement of mAb-containing medium with fresh medium. This description of antibody-mediated inhibition of EBV release might lead to the characterization of another form of immune defense for the control of EBV infections.
Asunto(s)
Anticuerpos Monoclonales/fisiología , Antígenos de Superficie/inmunología , Antígenos Virales/inmunología , Linfoma de Burkitt/inmunología , Herpesvirus Humano 4/metabolismo , Inmunosupresores/farmacología , Animales , Anticuerpos Monoclonales/biosíntesis , Antígenos de Superficie/análisis , Antígenos de Superficie/aislamiento & purificación , Antígenos Virales/análisis , Antígenos Virales/aislamiento & purificación , Linfoma de Burkitt/microbiología , Linfoma de Burkitt/terapia , Línea Celular , Epítopos , Herpesvirus Humano 4/inmunología , Humanos , Ratones , Ratones Endogámicos BALB C , Peso Molecular , Pruebas de Neutralización , Ácido Fosfonoacético/farmacologíaRESUMEN
The p35 protein which is hyperexpressed on hairy leukemic cells was determined to be Ii, the electrophoretically invariant glycoprotein that is associated with class II major histocompatibility complex (Ia) antigens from the time of their synthesis. The principal function of class II MHC antigens is to present to T cell receptors those digested foreign antigenic peptides that probably fold as amphipathic alpha-helices and adsorb to a hydrophobic surface (desetope) on Ia. By a novel strip-of-helix hydrophobicity algorithm we found that the sequence Leu-142 to His-170 in Ii formed a five-cycle, amphipathic, alpha-helix, the highest scoring one among a series of proteins commonly used as experimental antigens. This finding led to the hypothesis that this sequence in Ii bound to the antigen-binding site (desetope) of Ia until release and self-aggregation in the endosome in order that digested foreign peptides could then bind to Ia. Abundant expression of Ii in leukemic cells might be associated with an altered capacity of those cells to present foreign or leukemic antigens to the host's immune system.
Asunto(s)
Antígenos de Diferenciación de Linfocitos B , Antígenos de Histocompatibilidad Clase II/metabolismo , Leucemia de Células Pilosas/metabolismo , Proteínas de la Membrana/metabolismo , Línea Celular Transformada , Transformación Celular Viral , Herpesvirus Humano 4 , Humanos , Peso Molecular , Sialoglicoproteínas/metabolismo , Células Tumorales CultivadasRESUMEN
Confluent cultured normal human skin fibroblasts from neonatal, adult and aged donors have been stimulated to respond to wounding of the cell sheet. The latent period prior to initial migration of cells from the leading edge of the monolayer is correlated with in vitro population doubling level and in vivo donor age. Time-lapse photography of areas along the edge of the cell sheet reveals a specific pattern of migration by which the cells reestablish a confluent monolayer.
Asunto(s)
Envejecimiento , Piel/citología , Células Cultivadas , Fibroblastos/citología , Humanos , Cicatrización de HeridasAsunto(s)
Infecciones por Herpesviridae/microbiología , Herpesvirus Humano 4/aislamiento & purificación , Leucemia de Células Pilosas/microbiología , Animales , Anticuerpos Antivirales/análisis , Formación de Anticuerpos , Transformación Celular Neoplásica , Genes Virales , Infecciones por Herpesviridae/complicaciones , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/inmunología , Humanos , Leucemia de Células Pilosas/complicaciones , Leucemia de Células Pilosas/inmunología , RatonesAsunto(s)
Quitina/metabolismo , Quitinasas/metabolismo , Hongos/enzimología , Análisis de Varianza , Autorradiografía , Cadmio/farmacología , Isótopos de Carbono , Pared Celular/enzimología , Quitinasas/antagonistas & inhibidores , Cromatografía , Cobre/farmacología , Liofilización , Concentración de Iones de Hidrógeno , Hidrólisis , TemperaturaRESUMEN
Two proteins, p70 and p80, were found in chemically crosslinked complexes with class II MHC molecules and Ii after 3-12 hr labelings with [35S]methionine. Two-dimensional, nonreduced/reduced SDS gel electrophoresis of immunoprecipitated complexes revealed 1) endogenous disulfide linkages between Ii-Ii and Ii-p70 and 2) chemically crosslinked, nearest neighbors of alpha-beta, alpha-Ii, Ii-p70, and alpha-p80. Although such nearest neighbors within multimeric complexes were identified as dimers in nonreduced/reduced 2D gels, stoichiometries could not be determined in the high molecular weight complex(es), which included alpha, beta, Ii, p70, and p80, and were not separated in the first dimension. p80 was not the chondroitin-sulfate form of Ii (Ii-CS) because it was not electrophoretically heterogeneous and was not sensitive to chondroitinase ABC. p70 was not hsp72/74 detected with C92 or N27 mAbs, and p80 was not BiP detected with its respective mAb. While only these two proteins associated prominently with class II MHC antigens and Ii late after synthesis, their functions are unknown.
Asunto(s)
Antígenos de Diferenciación de Linfocitos B , Antígenos de Histocompatibilidad Clase II/aislamiento & purificación , Proteínas/aislamiento & purificación , Anticuerpos Monoclonales , Antígenos de Neoplasias/aislamiento & purificación , Línea Celular , Electroforesis en Gel Bidimensional , Proteínas de Choque Térmico/aislamiento & purificación , Antígenos de Histocompatibilidad Clase II/genética , Humanos , Cinética , Metionina/metabolismo , Peso Molecular , Unión Proteica , Biosíntesis de ProteínasRESUMEN
Antibodies to either Ii or class II major histocompatibility complex (MHC) antigens did not recognize cell surface forms of Ii in immunoprecipitates of cells that had been radioiodinated by the lactoperoxidase method, whereas they bound [35S]methionine metabolically labeled molecules. N-hydroxysuccinimidobiotin (NHS-B) and biotin hydrazide (B-H) were used to react more generally with cell surface proteins via amino groups and nitrene coupling, respectively. Each of these latter compounds labeled alpha and beta chains of class II MHC antigens as seen in Western-blotted, electrophoresed immunoprecipitates probed with 125I-labeled streptavidin but not Ii or its associated forms. Although tyrosine residues might have been inaccessible to radioiodination in carbohydrate-derivatized forms of Ii, the lack of Ii biotinylation in these controlled, sensitive studies was consistent with the view that Ii forms were not surface expressed, with the possible exception of the chondroitin sulfate-derivatized forms of Ii (Ii-CS).
Asunto(s)
Antígenos de Superficie/análisis , Biotina , Técnica del Anticuerpo Fluorescente , Antígenos HLA/análisis , Radioisótopos de Yodo , Biotina/análogos & derivados , Butiratos/farmacología , Ácido Butírico , Línea Celular , Antígenos HLA/clasificación , HumanosRESUMEN
We synthesized three peptides, MA1 - Thr19-Val28(+Tyr) -, MA2 - Ser807-Ala816-, and MA3-Ser718-Glu729(+Tyr) from the sequence of Epstein-Barr virus gp350/220 and immunized rabbits with these peptides. Rabbit antisera to the peptides had antipeptide radioimmunoassay titers of 1:400 for anti-MA1, 1:200 for anti-MA2, and 1:1600 for anti-MA3. The anti-MA1 serum recognized gp350/220 in Western blotting to SDS-electrophoresed proteins from 12-O-tetradecanoylphorbol-13-acetate- and n-butyrate-treated B95-8 cells, but anti-MA2 and MA3 sera did not. None of the sera reacted with gp350/220 by membrane or cytoplasmic immunofluorescence or by immunoprecipitation of Triton X-100 solubilized proteins.
Asunto(s)
Antígenos Virales/inmunología , Herpesvirus Humano 4/inmunología , Oligopéptidos/inmunología , Proteínas de la Matriz Viral , Animales , Línea Celular , Epítopos/análisis , Técnica del Anticuerpo Fluorescente , Pruebas de Precipitina , RadioinmunoensayoRESUMEN
We tested the hypothesis that Epstein-Barr virus (EBV) might actually infect leukemic hairy cells in vivo by examining those cells for the EBV-receptor, EBV nuclear antigen (EBNA) and membrane antigen (MA), for spontaneous transformation and rescue of infectious virus and for presence of EBV genome. EBV-receptors were found on subpopulations of leukemic cells from each of 7 patients with hairy cell leukemia (HCL) tested. MA was present on low numbers (1-5 per cent) of fresh leukemic cells of 7 patients and in some instances occurred with a greater frequency after 3 to 5 days in culture, with or without 12-O-tetradecanoylphorbol-13-acetate. In 11 fresh leukemic cell preparations from 8 HCL patients, no EBNA was demonstrated. However, 2 samples after 4 days in culture expressed low frequencies of EBNA-positive cells. Spontaneous, EBV-positive cell lines were established with a high transformation efficiency from 3 HCL blood samples but not from 8 other specimens. Infectious EBV could be rescued from some hairy leukemic cell preparations by co-cultivation with cord blood lymphocytes. These results demonstrated that leukemic cell populations harbored infectious EBV, that the leukemic cells expressed virus receptors and suggested that a small subpopulation of leukemic cells might become infected in vivo at least transiently and possibly transformed in vitro by EBV. To test for the extent of occult in vivo infection of leukemic cells with EBV, Southern type hybridization studies were performed with a probe for EBV genome (Bam HI W). At a sensitivity level of 0.1 genome per cell, EBV genome was not detected in the leukemic cell populations of 7 patients. We conclude that host defence mechanisms protecting these individuals from EBV also prevent infections of the leukemic cell and/or most hairy leukemic cells are not suitable targets for both infection and transformation.
Asunto(s)
Infecciones por Herpesviridae/microbiología , Herpesvirus Humano 4 , Leucemia de Células Pilosas/microbiología , Proteínas de la Matriz Viral , Antígenos Virales/análisis , Línea Celular , Transformación Celular Neoplásica/inmunología , Transformación Celular Viral , Antígenos Nucleares del Virus de Epstein-Barr , Sangre Fetal/microbiología , Genes Virales , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/inmunología , Herpesvirus Humano 4/metabolismo , Humanos , Leucemia de Células Pilosas/inmunología , Leucemia de Células Pilosas/metabolismo , Receptores de Complemento 3d , Receptores Virales/análisisRESUMEN
A functional role of class II antigen in the binding of Epstein-Barr virus (EBV) was deduced from the study of membrane proteins on Jijoye, an EBV receptor (EBVR)-positive B cell line, and its mutant, EBVR-negative daughter cell line, P3HR-1. From gel electrophoresis of radiolabeled microsomal membrane proteins and immunoprecipitates, we identified class II antigen on Jijoye but not on P3HR-1 cells and the presence of Ii on both cell lines. The role of these molecules in EBVR function was tested by antibody blocking of virus adsorption. Anti-p23,30 serum (to class II antigen) was found to block binding of EBV to B lymphoblasts under conditions in which normal rabbit serum, rabbit antiserum to butyrate-treated P3HR-1 cells (with ample anti-Ii antibodies), and rabbit anti-p44,12 (to class I antigen and beta 2-microglobulin) serum did not block virus binding. Only one of four commercial monoclonal antibodies (MoAb) to framework epitopes on class II antigens blocked binding of EBV, whereas all four MoAb demonstrated immunofluorescent reactivity with the EBVR+ Raji cells. In previous studies of binding of EBV to hairy leukemic cells, a substantial subpopulation of HLA-DR+, EBVR- cells was identified, in addition to HLA-DR+, EBVR+ cells. These findings were consistent with the view that the HLA-DR complex has a role in the binding of EBV but that other components are also needed for the expression of EBVR function.
Asunto(s)
Antígenos de Superficie/análisis , Herpesvirus Humano 4/metabolismo , Antígenos de Histocompatibilidad Clase II/análisis , Receptores Virales/fisiología , Animales , Anticuerpos Antineoplásicos/fisiología , Antígenos de Superficie/inmunología , Suero Antilinfocítico/farmacología , Unión Competitiva , Linfoma de Burkitt/inmunología , Linfoma de Burkitt/microbiología , Línea Celular , Electroforesis en Gel de Poliacrilamida , Antígenos HLA-DR , Antígenos de Histocompatibilidad Clase II/inmunología , Humanos , Proteínas de la Membrana/análisis , Proteínas de Neoplasias/análisis , Conejos , Receptores de Complemento 3d , Receptores Virales/análisisRESUMEN
The processing of antigenic peptides for presentation by MHC molecules to T cells, may depend upon the function of a second, consensus sequence in or near the T cell-presented epitope. One such processing-regulating sequence appears to be composed of amino acids Leu, Ile, Val, Phe, and Met recurring in a fashion to form a longitudinal, hydrophobic strip when the excised peptide is coiled as an alpha-helix. Such a hydrophobic strip-of-helix may: (a) scavenge peptides from lumens onto lipid membranes of digestion vesicles, (b) stabilize peptides there as protease-resistant helices, (c) specify recognition by the antigenic peptide-binding sites of chaperonin proteins, transmembranal transporters, or MHC molecules. By circular dichroism and electron paramagnetic resonance, we demonstrated that peptides with recurrent hydrophobic residues potentially forming longitudinal strips adsorbed to, and partially coiled as helices on, di-O-hexadecyl, D-L-alpha-phosphatidylcholine (DHPC) vesicles. Cathepsin B or cathepsin D cleavages of three such peptides were identified. With either enzyme, it made no significant difference whether a peptide substrate was in solution or bound to vesicles in terms of efficiency and specificity of peptide bond cleavages. We conclude that protease resistance, per se, of membrane-adsorbed, helically coiled peptides is not a major factor in the selection for T cell presentation of epitopes in peptides which have a motif with a longitudinal hydrophobic strip.
Asunto(s)
Catepsina B/metabolismo , Catepsina D/metabolismo , Liposomas , Fragmentos de Péptidos/química , Estructura Secundaria de Proteína , Adsorción , Secuencia de Aminoácidos , Animales , Células Presentadoras de Antígenos/metabolismo , Espectroscopía de Resonancia por Spin del Electrón , Datos de Secuencia Molecular , Fragmentos de Péptidos/efectos de los fármacos , Éteres Fosfolípidos , Especificidad por SustratoRESUMEN
In order to assess the role of Epstein-Barr virus (EBV) in patients with hairy cell leukemia (HCL), we have sought to characterize 1) the ability of EBV to infect and transform hairy leukemic cells in vitro and 2) the phenotypes of cell lines putatively derived from those leukemic cells. Analysis of EBV-induced transformation and the kinetics of Epstein-Barr nuclear antigen (EBNA) induction in leukemic preparations indicated that most leukemic cells were not susceptible to EBV infection but that at least a small subpopulation of leukemic cells could be infected with EBV. Lymphoblastoid cells lines were established after exposure of peripheral blood or splenic cells from HCL patients to B95-8 or QIMR-WIL EBV. Splenic leukemic cell preparations were more sensitive targets for EBV transformation than were peripheral blood cell samples. The newly established cell lines, but not long-established B lines such as Raji, demonstrated high levels of synthesis of p35, (a protein complex expressed abundantly by cells of a subset of HCL patients) and high levels of tartrate-resistant acid phosphatase (an enzyme relatively diagnostic for HCL). Lymphoblastoid lines from one patient with HCL expressed lambda light chains and no kappa chains as did the patient's leukemic cells. Virus expression in these lines showed that HCL-derived lines had spontaneous early antigen (EA) and viral capsid antigen (VCA) expression. Transforming EBV could be rescued from HCL-derived cell lines but not from cord blood-derived lines.